Dr Kwek Kon Yew

Director

Kon Yew leads the clinical development of new medicines, particularly for the treatment of cancer, at a HKEX-listed biotechnology company. Seeing how his family members fought battles against cancer has stirred in him a strong desire to serve the needs of terminally ill patients. Through AWS, he hopes to add life to days in patients with life-limiting illnesses and partner with communities to care for the dying. Kon Yew holds postgraduate diplomas in Family Medicine and Palliative Medicine.